Showing results (3201-3210 of 9,907) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 22, 2000
Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantationF Z Wang, A Linde, H Dahl, et al.
Bone Marrow Transplantation|March 21, 2000
Mini-allografts: ongoing trials in humansA M Carella, R Champlin, S Slavin, et al.
Bone Marrow Transplantation|March 21, 2000
Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectivesE Jantunen, R Myllykangas-Luosujärvi
Bone Marrow Transplantation|March 21, 2000
Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood cellsD Frasca, F Guidi, M Arbitrio, et al.
Bone Marrow Transplantation|March 21, 2000
Detection of an anti-RhD antibody 2 years after sensitization in a patient who had undergone an allogeneic BMTG Gandini, M Franchini, M de Gironcoli, et al.
Bone Marrow Transplantation|March 14, 2000
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status reportM A Gertz, M Q Lacy, A Dispenzieri
Bone Marrow Transplantation|March 14, 2000
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycleA Bashey, S Corringham, J Garrett, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|March 14, 2000
Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donorsK Miyamura, M Hamaguchi, H Taji, et al.
Bone Marrow Transplantation|April 4, 2000
A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignanciesT Demirer, O Ilhan, N M Mandel, et al.
Pageof 991